Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Lo Biosciences Inc. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, which indicates a very narrow prosecution focus for the company at this stage. The presence of 1 distinct art unit suggests that the company's intellectual property efforts are currently concentrated within a specific technical niche of the biotechnology sector.
The busiest examiner for the portfolio is MIANO, JOSEPH PAUL, who is responsible for 1 pending office action. For a practitioner, this means that the entirety of the company's immediate patent office interaction is localized with this single individual. This concentration allows for a highly tailored strategy that accounts for the specific preferences and examination style of MIANO, JOSEPH PAUL without the complexity of multiple examiners.
With 1 pending office action and 1 distinct art unit, the administrative footprint of the portfolio is minimal. This allows for a precise approach to the 1 distinct examiner involved. However, the lack of diversity in the portfolio means there are no other active cases to provide a baseline for comparison or to mitigate the risks associated with a single examiner's discretion.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIANO, JOSEPH PAUL | 1 | 36.0% | +63.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19214187 | MAGNETIC CAPTURE DEVICE | MIANO, JOSEPH PAUL | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19214187 | MAGNETIC CAPTURE DEVICE | MIANO, JOSEPH PAUL | 1631 | §103DP | Non-Final OA | — | Pending | May 21, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial